Russell Investments »

Mineralys Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $219 17 12.88
2023-12-31 $50k 5.8k 8.60
2023-09-30 $97k 10k 9.51

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Prologis Common Stock (PLD)
Unitedhealth Group Common Stock (UNH)
Eli Lilly And Company Common Stock (LLY)
Equinix Common Stock (EQIX)
Welltower Common Stock (WELL)
Visa Common Stock (V)

View all positions for Russell Investments

Top funds holding Mineralys Therapeutics

Samsara BioCapital
RA Capital Management
Braidwell
Sr One Capital Management
BlackRock
Laurion Capital Management
Vanguard Group
Sphera Funds Management
Franklin Resources
Blue Owl Capital Holdings
Millennium Management
Point72 Asset Management
Charles Schwab Investment Management
Citadel Advisors
Two Sigma Investments

View all funds holding Mineralys Therapeutics